240 related articles for article (PubMed ID: 33376561)
1. TRPV2: A Cancer Biomarker and Potential Therapeutic Target.
Siveen KS; Nizamuddin PB; Uddin S; Al-Thani M; Frenneaux MP; Janahi IA; Steinhoff M; Azizi F
Dis Markers; 2020; 2020():8892312. PubMed ID: 33376561
[TBL] [Abstract][Full Text] [Related]
2. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.
Santoni G; Amantini C; Maggi F; Marinelli O; Santoni M; Nabissi M; Morelli MB
Lab Invest; 2020 Feb; 100(2):186-198. PubMed ID: 31653969
[TBL] [Abstract][Full Text] [Related]
3. Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression.
Liberati S; Morelli MB; Amantini C; Santoni M; Nabissi M; Cardinali C; Santoni G
Curr Protein Pept Sci; 2014; 15(7):732-7. PubMed ID: 25001513
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
5. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
[TBL] [Abstract][Full Text] [Related]
6. The expression and role of TRPV2 in esophageal squamous cell carcinoma.
Kudou M; Shiozaki A; Yamazato Y; Katsurahara K; Kosuga T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
Sci Rep; 2019 Nov; 9(1):16055. PubMed ID: 31690728
[TBL] [Abstract][Full Text] [Related]
7. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation.
Siveen KS; Prabhu KS; Parray AS; Merhi M; Arredouani A; Chikri M; Uddin S; Dermime S; Mohammad RM; Steinhoff M; Janahi IA; Azizi F
Sci Rep; 2019 Feb; 9(1):1554. PubMed ID: 30733502
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
Marinelli O; Morelli MB; Annibali D; Aguzzi C; Zeppa L; Tuyaerts S; Amantini C; Amant F; Ferretti B; Maggi F; Santoni G; Nabissi M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751388
[TBL] [Abstract][Full Text] [Related]
10. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
11. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression.
Liberati S; Morelli MB; Amantini C; Farfariello V; Santoni M; Conti A; Nabissi M; Cascinu S; Santoni G
Cells; 2014 Feb; 3(1):112-28. PubMed ID: 24709905
[TBL] [Abstract][Full Text] [Related]
12. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.
Yamada T; Ueda T; Shibata Y; Ikegami Y; Saito M; Ishida Y; Ugawa S; Kohri K; Shimada S
Urology; 2010 Aug; 76(2):509.e1-7. PubMed ID: 20546877
[TBL] [Abstract][Full Text] [Related]
13. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner.
Nabissi M; Morelli MB; Amantini C; Farfariello V; Ricci-Vitiani L; Caprodossi S; Arcella A; Santoni M; Giangaspero F; De Maria R; Santoni G
Carcinogenesis; 2010 May; 31(5):794-803. PubMed ID: 20093382
[TBL] [Abstract][Full Text] [Related]
14. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
Morelli MB; Offidani M; Alesiani F; Discepoli G; Liberati S; Olivieri A; Santoni M; Santoni G; Leoni P; Nabissi M
Int J Cancer; 2014 Jun; 134(11):2534-46. PubMed ID: 24293211
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
[TBL] [Abstract][Full Text] [Related]
16. Recurrent activations of transient receptor potential vanilloid-1 and vanilloid-4 promote cellular proliferation and migration in esophageal squamous cell carcinoma cells.
Huang R; Wang F; Yang Y; Ma W; Lin Z; Cheng N; Long Y; Deng S; Li Z
FEBS Open Bio; 2019 Feb; 9(2):206-225. PubMed ID: 30761248
[TBL] [Abstract][Full Text] [Related]
17. Novel role of TRPV2 in promoting the cytotoxicity of H2O2-mediated oxidative stress in human hepatoma cells.
Ma W; Li C; Yin S; Liu J; Gao C; Lin Z; Huang R; Huang J; Li Z
Free Radic Biol Med; 2015 Dec; 89():1003-13. PubMed ID: 26456053
[TBL] [Abstract][Full Text] [Related]
18. TRPV2.
Kojima I; Nagasawa M
Handb Exp Pharmacol; 2014; 222():247-72. PubMed ID: 24756709
[TBL] [Abstract][Full Text] [Related]
19. Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.
Iwata Y; Matsumura T
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394715
[TBL] [Abstract][Full Text] [Related]
20. Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells.
Che H; Xiao GS; Sun HY; Wang Y; Li GR
J Cell Mol Med; 2016 Jun; 20(6):1118-27. PubMed ID: 26865051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
